Lactosucrose (4G-B-D-galactosylsucrose) was fermented in vitro by bifidobacteria and lactobacilli, and to a limited degree by the Bacteroides fragilis group, clostridia, eubacteria, and enterobacteriaceae. The effects of dietary lactosucrose on the fecal flora and fecal metabolites were studied in eight healthy volunteers (20-23 years of age) who ingested 3 g of lactosucrose/day for 7 days followed by 6 g of lactosucrose/day for 7 consecutive days. During lactosucrose intake, the counts of bifidobacteria were increased significantly (p< 0.001), whereas the counts of clostridia, including Clostridium perfringens, and bacteroidaceae were decreased significantly (p<0.05) compared with the values before the intake. The total bacterial counts were decreased significantly (p< 0.05) on day 14 during the intake. The frequency of occurrence of lecithinase-negative clostridia was decreased significantly (p<0.05) when compared with the values before and after the intake. No detectable changes occurred in the counts of other organisms throughout the experimental periods. Fecal concentrations of ammonia, sulfide, phenol, ethylphenol, skatol and indole were decreased significantly (p< 0.05) during lactosucrose intake. Acetic acid and lactic acid were increased significantly (p< 0.05) during the intake. Fecal enzyme activity of B-glucuronidase was decreased significantly (p< 0.05) on day 14 of the intake. Serum very low density lipoprotein (VLDL) was increased significantly (p< 0.01) on day 14 during the intake. Mean fecal pH values decreased from 6.3 to 5.9, and mean water content increased 3.6% during the intake. Fecal weight was increased slightly during the intake. The results obtained showed that the effective dose of lactosucrose for all healthy adults is 3 g/day.
solution containing 5 mM p-toluenesulfonic acid and 100 mM EDTA) , 0.8 ml/ min. Fecal contents of indole, skatol and phenols were analyzed by gas chromatography using the method of Yoshihara (35) . Fecal enzyme activities were determined using the method of Rowland et al. (24) . Assay of serum lipids. Serum phospholipids (27), triglycerides (16), free fatty acids (26), and cholesterol (13) were measured enzymatically, and lipoprotein was measured by use of a turbidimetric method (25) and agarose gel electrophoresis assay (23) .
Measurement of fecal properties. Fecal water contents were measured by using approximately 1 g samples weighed before and after drying in a vacuum oven 625 (Ikemoto Rika Kogyo Co., Ltd., Tokyo) at 105°C. Fecal pH values were determined with a flat glass electrode (DKK Co., Ltd., Tokyo) . The weight of fecal output for 24 hr was measured for 3 consecutive days, including the days of sampling for the bacterial analyses.
Statistical analysis of data. Student's t-test and the method of Fisher's direct probability calculation were used for statistical analysis of the fecal flora. Student's t-test was used for analysis of pH value, moisture content, weight, enzyme activities and metabolites of feces and serum lipids.
RESULTS

Utilization of LS In Vitro
The results of fermentation test in vitro of six saccharides including LS are shown in Table 3 . LS was fermented by all the bifidobacteria tested, lactobacilli including L. acidophilus, L. salivarius and L. casei as effectively as glucose , and other b acteria, such as Bacteroides fragilis group, clostridia, Staphylococcus aureus, Enterococcus faecalis, bacilli, Salmonella, and Escherichia coli to a lesser degree than glucose. FOS, SOR and raffinose showed similar fermentation patterns , except that they were not fermented by B. bifidum, L. casei, C. paraputrificum, E. coli , and Salmonella (except for raffinose).
Fecal Flora Analysis
The effects of LS intake on the composition of fecal flora are shown in Table 4 . The levels of bifidobacteria were significantly (p <0.001 ) increased during LS intake , while the levels of lecithinase-positive clostridia including Clostridium perfringens and bacteroidaceae were significantly (p<0.05) decreased during the intake , expect for the levels of C. perfringens in one volunteer. The percentage of bifidobacteria to total bacteria were improved from 10.5% before the intake to 38.9% and 38 .1% on days 7 and 14 in the LS period, respectively. The levels of total bacteria were significantly (p <0.05) decreased on day 14 in the LS period. In frequency of occurrence, lecithinase-negative clostridia during LS intake were decreased significantly (p <0.05) when compared with before and after the intake . No detectable changes occurred in the levels of other organisms throughout the experimental period. Fecal Metabolic Products A significant decrease (p<0.05) in the amounts of fecal ammonia, sulfide, indole, phenol, and skatol were observed during LS intake, compared with those before the intake (Table 5) .
The concentrations of total organic acids, lactic acid, and acetic acid were significantly (p<0.05) increased during the intake (Table 6 ) . 
DISCUSSION
Although Fujita et al. (6) reported that LS was fermented by all species of Bifidobacterium, except for B. bifidum in vitro, our results showed that LS was fermented by all Bifidobacterium species including B. bifidum. The fermentation of LS by the intestinal bacteria was similar to that of lactulose (9) .
LS escapes digestion by intestinal enzymes. Thus, it is not absorbed in the small intestine, and passes directly into the colon where it is fermented by LS-fermenting bacteria such as bifidobacteria which produces short chain fatty acids. The significant increase observed in bifidobacteria during LS intake (3 g or 6 g/day) was similar to those during intake of various oligosaccharides [lactulose 3 g (29), xylooligosaccharides 5 g (22), FOS 8 g (9), 4'-galactosyllactose 8 g (20) , galacto-oligosaccharides 10 g (12), transgalactosyl oligosaccharides (TOS) 10 g (18), soybean oligosaccharides extract (SOE) 10 g (8), palatinose 12 g (14), isomaltooligosaccharides 13.5 g (15) , raffinose 15 g (2) , or lactulose 30 g (11) per day] for healthy adults.
The significant decrease observed in C. perfringens, lecithinase-negative clostridia and bacteroidaceae during LS intake was similar to those during intake of raffinose (2), TOS (28), and lactulose (29), and suggests that an increase in fermentative anaerobes inhibits the growth of proteolytic bacteria during lactulose administration as reported by Vince et al. (33) .
A decrease in clostridia has not been observed during intake of other oligosaccharides in previous reports (8, 9, 12, 14, 15, 20, 22) . The discrepancies between our data and hitherto reported results may be due to heat treatment to detect lecithinase-positive clostridia and the use of Medium 10 for lecithinase-negative clostridia in our study, because the detection rate of clostridia (lecithinase-positive and lecithinase-negative) was markedly increased when these methods were used (unpublished data) .
The tendency for enterobacteriaceae to decrease by day 14 during LS intake was similar to that of lactulose intake (29) but not to that of TOS (3 g/day) (28) . The significant decrease in bacteroidaceae during LS intake showed a negative correlation with the increase in the number of fecal bifidobacteria and contributed to the decrease in total bacteria.
The putrefactive products in the human intestine are mainly composed of 
